arrow
J

Jason G. Kettle

GlaxoSmithKline
H指数:31
被引数:3,394

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor

吡嗪羧酰胺AZ3246的发现与优化:一种选择性HPK1抑制剂

2025-02-102
PRE
Design of a Lead-Like Cysteine-Targeting Covalent Library and the Identification of Hits to Cys55 of Bfl-1
2024-06-251
PRE
Metabolism-driven in vitro/in vivo disconnect of an oral ERα VHL-PROTAC
2024-05-135
OAAI
Discovery of the Potent and Selective Inhaled Janus Kinase 1 Inhibitor AZD4604 and Its Preclinical Characterization
2023-09-223
PRE
Discovery of AZD4747, a Potent and Selective Inhibitor of Mutant GTPase KRASG12C with Demonstrable CNS Penetration

AZD4747的发现,这是一种有效且选择性的突变体GTPase KRASG12C抑制剂,具有明显的中枢神经系统穿透性

2023-07-0311
PRE
Discovery of Clinical Candidate AZD0095, a Selective Inhibitor of Monocarboxylate Transporter 4 (MCT4) for Oncology

发现临床候选药物AZD0095,一种用于肿瘤学的单羧酸转运蛋白4 (MCT4) 的选择性抑制剂

2022-12-1623
PRE
AZD4625 is a Potent and Selective Inhibitor of KRASG12C
2022-08-052
OAAI
Discovery of AZD4625, a Covalent Allosteric Inhibitor of the MutantGTPase KRASG12C

突变gtpase KRASG12C的共价变构抑制剂AZD4625的发现

2022-04-2637
PRE
Alkynyl Benzoxazines and Dihydroquinazolines as Cysteine Targeting Covalent Warheads and Their Application in Identification of Selective Irreversible Kinase Inhibitors
2020-05-1552
OAAI
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors
2020-04-2923
OAAI
Discovery of (2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide (AZD4205) as a Potent and Selective Janus Kinase 1 Inhibitor

发现 (2R)-N-[3-[2-[(3-甲氧基-1-甲基-吡唑-4-基) 氨基] pyrimidin-4-yl]-1h-吲哚-7-基]-2-(4-甲基哌嗪-1-基) 丙烯酰胺 (AZD4205) 作为有效和选择性的Janus激酶1抑制剂

2020-04-1639
PREAI
Structure-Based Design and Pharmacokinetic Optimization of Covalent Allosteric Inhibitors of the Mutant GTPase KRASG12C
2020-02-0560
PREAI